Canada markets closed

Agile Therapeutics, Inc. (AGRX)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
Add to watchlist
0.3548-0.0033 (-0.92%)
At close: 01:34PM EDT

Agile Therapeutics, Inc.

500 College Road East
Suite 310
Princeton, NJ 08540
United States
609 683 1880
https://www.agiletherapeutics.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees19

Key Executives

NameTitlePayExercisedYear Born
Mr. Alfred F. AltomariChairman, President & CEO646.53kN/A1959
Mr. Scott M. CoianteCFO, Senior VP & Treasurer436.91kN/A1967
Mr. Geoffrey P. GilmoreSenior VP & Chief Administrative Officer494.85kN/A1966
Dr. Paul Korner M.B.A., M.D.Senior VP & Chief Medical Officer494.6kN/A1966
Mr. Robert G. Conway M.E.Senior VP and Chief Corporate Planning & Supply Chain Officer444.11kN/A1957
Ms. Amy WelshSenior VP & Chief Commercial OfficerN/AN/A1971
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Agile Therapeutics, Inc., a women's healthcare company, engages in the research, development, and commercialization of prescription contraceptive products for women in the United States. It offers Twirla, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend the length of her contraceptive cycle, as well as have shorter and lighter withdrawal bleeding episodes per year; and P-Patch, a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.

Corporate Governance

Agile Therapeutics, Inc.’s ISS Governance QualityScore as of June 1, 2024 is 9. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.